Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05867381 · ClinicalTrials.gov registry record · NA

Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History

A NA study of Atherosclerosis and Air Pollution, sponsored by University of Southern California.

Recruiting
Registry status
NA
Development phase
112
Enrollment target
1
Study location

NCT05867381 is a NA study of Atherosclerosis and Air Pollution that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 112 participants, below the 1,064-participant average among 69 other Atherosclerosis trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05867381, a NA study of Atherosclerosis and Air Pollution, is actively recruiting participants, sponsored by University of Southern California.

RECRUITING
Registry status
NA
Development phase
112 participants
Enrollment target
1
Study location

Study Summary

This double-blind, randomized, crossover trial aims to test the hypothesis that longer-term indoor air filtration intervention can slow atherothrombosis progression by reducing indoor fine particulate matter (PM2.5) exposure in adults with ischemic heart disease history.

Conditions Studied

Atherosclerosis Air Pollution

Interventions

  • DEVICE HEPA filtration
  • DEVICE Sham filtration

Study Locations (1)

California

  • Keck School of Medicine, University of Southern California - Los Angeles

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2023-07-11
Est. Completion 2027-06-30
Phase NA

Sponsor

University of Southern California

617 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05867381

The ClinicalTrials.gov registry entry for NCT05867381 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,064-participant average among 69 other Atherosclerosis trials with a reported enrollment target (89% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Atherosclerosis appearing as the primary indexed condition, and to 2 interventions - of which HEPA filtration is the first listed.

NCT05867381 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05867381 about?

NCT05867381 is a clinical study titled "Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History". This double-blind, randomized, crossover trial aims to test the hypothesis that longer-term indoor air filtration intervention can slow atherothrombosis progression by reducing indoor fine particulate matter (PM2.5) exposure in adults with ischemic heart disease history.

What is the current status of trial NCT05867381?

This trial is currently recruiting. It is a NA study. The enrollment target is 112 participants. The study started on 2023-07-11. Estimated completion is 2027-06-30.

What conditions does trial NCT05867381 study?

This clinical trial studies the following conditions: Atherosclerosis, Air Pollution.

What interventions are being tested in trial NCT05867381?

The interventions under investigation include: HEPA filtration (DEVICE), Sham filtration (DEVICE).

Who is sponsoring clinical trial NCT05867381?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05867381 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atherosclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atherosclerosis

All registered trials for this condition

Air Pollution

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.